Impaired inactivation of L-type Ca2+ current as a potential mechanism for variable arrhythmogenic liability of herg K+ channel blocking drugs

11Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

The proarrhythmic effects of new drugs have been assessed by measuring rapidly activating delayed-rectifier K+ current (IKr) antagonist potency. However, recent data suggest that even drugs thought to be highly specific IKr blockers can be arrhythmogenic via a separate, time-dependent pathway such as late Na+ current augmentation. Here, we report a mechanism for a quinolone antibiotic, sparfloxacin-induced action potential duration (APD) prolongation that involves increase in late L-type Ca2+ current (ICaL) caused by a decrease in Ca2+-dependent inactivation (CDI). Acute exposure to sparfloxacin, an IKr blocker with prolongation of QT interval and torsades de pointes (TdP) produced a significant APD prolongation in rat ventricular myocytes, which lack IKr due to E4031 pretreatment. Sparfloxacin reduced peak ICaL but increased late ICaL by slowing its inactivation. In contrast, ketoconazole, an IKr blocker without prolongation of QT interval and TdP produced reduction of both peak and late ICaL, suggesting the role of increased late ICaL in arrhythmogenic effect. Further analysis showed that sparfloxacin reduced CDI. Consistently, replacement of extracellular Ca2+ with Ba2+ abolished the sparfloxacin effects on ICaL. In addition, sparfloxacin modulated ICaL in a use-dependent manner. Cardiomyocytes from adult mouse, which is lack of native IKr, demonstrated similar increase in late ICaL and afterdepolarizations. The present findings show that sparfloxacin can prolong APD by augmenting late ICaL. Thus, drugs that cause delayed ICaL inactivation and IKr blockage may have more adverse effects than those that selectively block IKr. This mechanism may explain the reason for discrepancies between clinically reported proarrhythmic effects and IKr antagonist potencies.

References Powered by Scopus

Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K<sup>+</sup> channel HERG

288Citations
N/AReaders
Get full text

Mechanisms of arsenic-induced prolongation of cardiac repolarization

282Citations
N/AReaders
Get full text

Pentamidine-induced long QT syndrome and block of hERG trafficking

250Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative — Update on progress

317Citations
N/AReaders
Get full text

Specific prediction of clinical QT prolongation by kinetic image cytometry in human stem cell derived cardiomyocytes

30Citations
N/AReaders
Get full text

Enhanced late Na and Ca currents as effective antiarrhythmic drug targets

28Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kim, J. G., Sung, D. J., Kim, H. J., Park, S. W., Won, K. J., Kim, B., … Bae, Y. M. (2016). Impaired inactivation of L-type Ca2+ current as a potential mechanism for variable arrhythmogenic liability of herg K+ channel blocking drugs. PLoS ONE, 11(3). https://doi.org/10.1371/journal.pone.0149198

Readers' Seniority

Tooltip

Professor / Associate Prof. 4

36%

PhD / Post grad / Masters / Doc 4

36%

Researcher 3

27%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

36%

Pharmacology, Toxicology and Pharmaceut... 3

27%

Social Sciences 2

18%

Biochemistry, Genetics and Molecular Bi... 2

18%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 2

Save time finding and organizing research with Mendeley

Sign up for free